Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...16, 17, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-05-30
5:00 pm
Purchase
13DIcosavax, Inc.
ICVX
RA CAPITAL MANAGEMENT L.P.5,985,843
12.5%
206,496increase
(+3.57%)
View
2023-05-15
5:02 pm
Sale
13GTravere Therapeutics, Inc.
TVTX
RA CAPITAL MANAGEMENT L.P.0
0%
-3,984,681decrease
(Position Closed)
View
2023-05-15
5:01 pm
Sale
13GDA32 Life Science Tech Acquisition Corp.
DALS
RA CAPITAL MANAGEMENT L.P.0
0%
-1,500,000decrease
(Position Closed)
View
2023-05-15
5:01 pm
Sale
13GARYA Sciences Acquisition Corp V
ARYE
RA CAPITAL MANAGEMENT L.P.0
0%
-1,000,000decrease
(Position Closed)
View
2023-04-18
4:30 pm
Purchase
13DSatsuma Pharmaceuticals, Inc.
STSA
RA CAPITAL MANAGEMENT L.P.5,944,252
17.9%
30,000increase
(+0.51%)
View
2023-04-10
5:05 pm
Purchase
13GNanoString Technologies, Inc.
NSTG
RA CAPITAL MANAGEMENT L.P.2,577,373
5.5%
2,433,473increase
(+1691.09%)
View
2023-04-10
5:01 pm
Purchase
13DEliem Therapeutics, Inc.
ELYM
RA CAPITAL MANAGEMENT L.P.13,163,071
48.8%
11,112increase
(+0.08%)
View
2023-04-10
5:00 pm
Purchase
13GAscendis Pharma A/S
ASND
RA CAPITAL MANAGEMENT L.P.9,967,172
17.4%
3,009,993increase
(+43.26%)
View
2023-03-30
5:08 pm
Purchase
13GGH Research PLC
GHRS
RA CAPITAL MANAGEMENT L.P.5,561,118
10.7%
662,745increase
(+13.53%)
View
2023-03-30
5:07 pm
Purchase
13DAcrivon Therapeutics, Inc.
ACRV
RA CAPITAL MANAGEMENT L.P.4,817,359
22%
3,917increase
(+0.08%)
View
2023-03-30
5:02 pm
Purchase
13D89bio, Inc.
ETNB
RA CAPITAL MANAGEMENT L.P.12,876,898
18%
3,500,496increase
(+37.33%)
View
2023-03-29
5:14 pm
Purchase
13DDICE Therapeutics, Inc.
DICE
RA CAPITAL MANAGEMENT L.P.7,660,615
16.1%
811,704increase
(+11.85%)
View
2023-03-27
5:00 pm
Purchase
13GCureVac N.V.
CVAC
RA CAPITAL MANAGEMENT L.P.12,245,955
5.5%
12,245,955increase
(New Position)
View
2023-03-20
4:30 pm
Purchase
13GOrchard Therapeutics plc
ORTX
RA CAPITAL MANAGEMENT L.P.18,564,300
9.99%
18,564,300increase
(New Position)
View
2023-02-27
4:57 pm
Sale
13GEnliven Therapeutics Inc.
IMRA
RA CAPITAL MANAGEMENT L.P.2,122,465
5.2%
-1,128,259decrease
(-34.71%)
View
2023-02-24
4:30 pm
Purchase
13DMineralys Therapeutics, Inc.
MLYS
RA CAPITAL MANAGEMENT L.P.3,180,920
7.8%
3,180,920increase
(New Position)
View
2023-02-14
4:45 pm
Sale
13GThird Harmonic Bio, Inc.
THRD
RA CAPITAL MANAGEMENT L.P.534,687
1.3%
-2,941,000decrease
(-84.62%)
View
2023-02-14
4:45 pm
Purchase
13GCelcuity Inc.
CELC
RA CAPITAL MANAGEMENT L.P.2,249,421
9.9%
762,950increase
(+51.33%)
View
2023-02-14
4:45 pm
Sale
13GAscendis Pharma A/S
ASND
RA CAPITAL MANAGEMENT L.P.6,957,179
12.2%
-610,721decrease
(-8.07%)
View
2023-02-14
4:45 pm
Purchase
13GCONCERT PHARMACEUTICALS INC.
CNCE
RA CAPITAL MANAGEMENT L.P.5,199,746
9.99%
1,689,643increase
(+48.14%)
View
Goto 0, 1, 2, ...16, 17, Next